HANGZHOU COCO HEALTHCARE PRODUCTS CO.,LTD. Financials Hangzhou Coco Healthcare Products Co.,Ltd.
Equities
301009
CNE100004LL1
Personal Products
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.89 CNY | -2.31% |
|
-2.74% | -16.60% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,016 | 3,262 | 2,898 | 2,387 | - | - |
| Enterprise Value (EV) 1 | 5,016 | 3,262 | 2,898 | 2,387 | 2,387 | 2,387 |
| P/E ratio | - | -75 x | 152 x | 55.6 x | 42.3 x | 35.6 x |
| Yield | 0.38% | - | 0.7% | - | - | - |
| Capitalization / Revenue | 4.23 x | 2.75 x | 2.68 x | 1.97 x | 1.77 x | 1.62 x |
| EV / Revenue | 4.23 x | 2.75 x | 2.68 x | 1.97 x | 1.77 x | 1.62 x |
| EV / EBITDA | 54.5 x | 76.7 x | 36.8 x | 23 x | 21.2 x | 17.9 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | 3.55 x | 2.41 x | 2.11 x | 1.65 x | 1.54 x | 1.43 x |
| Nbr of stocks (in thousands) | 271,860 | 271,860 | 271,860 | 268,514 | - | - |
| Reference price 2 | 18.45 | 12.00 | 10.66 | 8.890 | 8.890 | 8.890 |
| Announcement Date | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,635 | 1,186 | 1,186 | 1,081 | 1,214 | 1,346 | 1,477 |
| EBITDA 1 | - | 92.11 | 42.54 | 78.74 | 103.7 | 112.6 | 133.2 |
| EBIT 1 | - | 45.3 | -55.47 | 20.23 | 50.87 | 63.53 | 78.26 |
| Operating Margin | - | 3.82% | -4.68% | 1.87% | 4.19% | 4.72% | 5.3% |
| Earnings before Tax (EBT) 1 | - | 43.53 | -56.37 | 19.45 | 49.74 | 62.38 | 77.27 |
| Net income 1 | - | 39.75 | -43.13 | 20.18 | 44.76 | 56.26 | 68.99 |
| Net margin | - | 3.35% | -3.64% | 1.87% | 3.69% | 4.18% | 4.67% |
| EPS 2 | 1.050 | - | -0.1600 | 0.0700 | 0.1600 | 0.2100 | 0.2500 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | 0.0700 | - | 0.0750 | - | - | - |
| Announcement Date | 5/26/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 3.92% | -3.12% | 1.48% | 3.06% | 3.59% | 4.08% |
| ROA (Net income/ Total Assets) | - | 2.22% | - | - | - | - | - |
| Assets 1 | - | 1,790 | - | - | - | - | - |
| Book Value Per Share 2 | - | 5.200 | 4.980 | 5.050 | 5.380 | 5.770 | 6.230 |
| Cash Flow per Share 2 | - | 0.1900 | -0.1400 | 0.8400 | -0.1700 | 1.150 | -0.5500 |
| Capex | - | 240 | 116 | 65.3 | - | - | - |
| Capex / Sales | - | 20.23% | 9.76% | 6.04% | - | - | - |
| Announcement Date | 5/26/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.89
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.60% | 337M | |
| +8.50% | 45.08B | |
| -0.86% | 18.35B | |
| -5.85% | 4.06B | |
| +3.08% | 3.61B | |
| +7.49% | 2.72B | |
| -19.00% | 1.51B | |
| +55.15% | 1.4B | |
| +14.09% | 943M | |
| +21.24% | 800M |
- Stock Market
- Equities
- 301009 Stock
- Financials Hangzhou Coco Healthcare Products Co.,Ltd.
